JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Generation of transgenic oriental melon resistant to Zucchini yellow mosaic virus by an improved cotyledon-cutting method.

Production of melon (Cucumis melo L.) worldwide is often limited by the potyvirus, Zucchini yellow mosaic virus (ZYMV). In order to engineer melon lines resistant to ZYMV, a construct containing the translatable coat protein (CP) sequence coupled with the 3' non-translatable region of the virus was generated and used to transform an elite cultivar of oriental melon (Silver light) mediated by Agrobacterium using an improved cotyledon-cutting method. Removal of 1-mm portion from the proximal end of cotyledons greatly increased the frequency of transgenic regenerants by significantly decreasing the incidence of false positive and aberrant transformants. Results of greenhouse evaluation of transgenic lines by mechanical challenge with ZYMV identified transgenic lines exhibiting different levels of resistance or complete immunity to ZYMV. Southern hybridization of transgenic lines revealed random insertion of the transgene in host genome, with insert numbers differing among transformants. Northern hybridization revealed great variations in the levels of accumulation of the transgene transcripts among transgenic lines, and evidenced an inverse correlation of the levels of accumulation of transgene transcript to the degrees of virus resistance, indicating post-transcriptional gene silencing (PTGS)-mediated transgenic resistance. These transgenic melon lines with high degrees of resistance to ZYMV have great potential for the control of ZYMV in East Asia.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app